Western Range Biopharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 19 Days
- Last Filing with ROC 31 Mar 2020
About Western Range Biopharmaceuticals
Western Range Biopharmaceuticals Private Limited (WRBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2012 and has a history of 13 years. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinod Kuberkar and Swapna Kuberkar serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24119MH2012PTC226409
-
Company No.
226409
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 2012
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Western Range Biopharmaceuticals Private Limited offer?
Western Range Biopharmaceuticals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Medical Treatment Services, Medical Surgery Services, Testing Services.
Who are the key members and board of directors at Western Range Biopharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Kuberkar
|
Director | 25-Jan-2012 | Current |
|
Swapna Kuberkar
|
Director | 25-Jan-2012 | Current |
Financial Performance of Western Range Biopharmaceuticals.
Western Range Biopharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Western Range Biopharmaceuticals?
In 2017, Western Range Biopharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vtk Lifesciences Advisory Services Private LimitedVinod Kuberkar and Swapna Kuberkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Western Range Biopharmaceuticals?
Unlock and access historical data on people associated with Western Range Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Western Range Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Western Range Biopharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.